Pharmaceuticals

Global Inhalation CDMO Market Overview: Trends Shaping Growth to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Inhalation CDMO Industry By The Forecast Year 2029?

The inhalation CDMO market has shown robust expansion over recent years. It is anticipated to expand further, reaching $2.2 billion in 2025 from $2.08 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 6.0%. This growth in previous periods can be linked to factors such as the increasing incidence of respiratory conditions, the growing requirement for personalized healthcare, the rise in outsourcing activities by pharmaceutical firms, and the general advancement of the biopharmaceutical sector.

The inhalation CDMO market is projected to experience significant expansion in the upcoming years. This market is anticipated to reach $2.84 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the projection period include an emphasis on precision medicine and targeted treatments, the swift growth of biopharmaceutical inhalation therapies, a focus on patient-focused solutions, the expansion into global markets and new market prospects, and regulatory assistance for the development of inhalation drugs. Key trends expected during the forecast period encompass a rising need for digital health innovations, advancements in biologic inhalation therapies, a commitment to sustainable inhaler technologies, the incorporation of artificial intelligence (AI) and machine learning, and strategic alliances and collaborations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp

Which Drivers Are Supporting Growth Of The Inhalation CDMO Market?

The rising occurrence of respiratory ailments is anticipated to drive the expansion of the inhalation CDMO market in the coming years. Respiratory disorders are a collection of medical conditions impacting the respiratory system, which comprises the organs and components essential for breathing. Inhalation CDMOs are instrumental in the creation and production of products for these disorders, leveraging their proficiency in developing and administering drugs directly to the lungs. They offer unique expertise, facilities, and resources to pharmaceutical companies aiming to introduce innovative inhalation treatments. For instance, data from the Australian Bureau of Statistics (ABS), an Australia-based Government agency, revealed that 8.5 million Australians (34%) reported having chronic respiratory conditions. This total included 2.8 million people (11%) with asthma and 638,000 people (2.5%) with COPD. Thus, the increasing prevalence of respiratory disorders is a significant force behind the growth of the inhalation CDMO market.

Which Key Segments Fueling The Inhalation CDMO Market?

The inhalation cdmo market covered in this report is segmented –

1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler

2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis

3) By Technology: Manual Inhalers (SMI), Digital Inhalers

4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs

2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs

3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers

4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices

What Are The Latest Industry Trends Transforming The Inhalation CDMO Market?

Leading companies in the inhalation CDMO industry are adopting strategic partnerships to deliver specialized drug development and delivery solutions. A strategic partnership involves a long-term, mutually beneficial arrangement where two or more companies collaborate to achieve shared objectives. For instance, in May 2023, Hovione, a Contract Development and Manufacturing Organization from Portugal, formed a partnership with H&T Presspart, a UK-based producer of high-precision metal and plastic components for the pharmaceutical sector, to advance Presspart’s Sunrise Capsule-based Dry Powder Inhaler platform. This collaboration aims to develop new technologies capable of delivering higher drug doses and improving the efficiency of drug delivery to the lungs.

Which Leading Companies Dominate The Inhalation CDMO Market Share?

Major companies operating in the inhalation CDMO market report are Pfizer Inc., Merck KGaA, Baxter’s BioPharma Solutions, Lonza Group AG, Catalent Inc., AptarGroup Inc., Samsung Biologics Co. Ltd., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, Cambrex Corporation, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Formosa Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Dipharma Francis Srl, Copley Scientific

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report

Which Region Currently Holds The Largest Share Of The Inhalation CDMO Market?

North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2024. The regions covered in the inhalation CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Inhalation CDMO Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13864&type=smp

Browse Through More Reports Similar to the Global Inhalation CDMO Market 2025, By The Business Research Company

Breast Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Cellulars Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795